Afasevikumab
Modify Date: 2025-08-25 20:03:06
Afasevikumab structure
|
Common Name | Afasevikumab | ||
|---|---|---|---|---|
| CAS Number | 1589503-30-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AfasevikumabAfasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1]. |
| Name | Afasevikumab |
|---|
| Description | Afasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Afasevikumab 由 N 末端 IL-17F 特异性部分、结合 IL-17A 和 IL-17F 的 a-C 末端部分以及结合人血清白蛋白的中心部分组成[1]。 |
| References |
| No Any Chemical & Physical Properties |